Journal
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Volume 17, Issue 2, Pages 345-352Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2018.09.029
Keywords
Clostridium difficile; fecal transplant; microbiome; FMT
Categories
Ask authors/readers for more resources
Clostridium difficile infection (CDI) has become the leading cause of nosocomial infection in the United States with significant risk of both morbidity and mortality. While antimicrobial therapy forms the basis of treatment, there are several clinical scenarios in which antimicrobial therapy alone is insufficient. Evidence continues to show the safety and efficacy fecal microbiota transplantation (FMT) in recurrent and severe CDI. This review will outline FMT efficacy, safety, and indications and present practical advice for clinicians interested in best practices around delivery of FMT.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available